Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EEF2K as modifiers of the PTEN/AKT pathway and methods of use

EEF2K as modifiers of the PTEN/AKT pathway and methods of use

US Patent 8679763 · Granted Mar 25, 2014

Estimated economic value: $6,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tert-butyl (s)-2-(4-(phenyl)-6H-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]dia2024
Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pi2018
Methods and compositions for modulating estrogen receptor mutants2018
USP7 inhibitor compounds and methods of use2017
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2016
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor com2015
SCDs as modifiers of the p53 pathway and methods of use2014
CDK9 as modifier of the IGF pathway and methods of use2014
PLKS as modifiers of the beta catenin pathway and methods of use2014
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic a2013
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2013
PIK4CA as modifier of the Rac pathway and methods of use2013